International Conference on Pharmaceuticals in the Environment
Scope
Pharmaceuticals have been widely detected in soils, surface waters and groundwater across the world. As they are bioactive substances, concerns have been raised about their potential impact on the environment.
ERAPharm 2007 will review the current state of knowledge concerning the inputs, fate, effects and risks of veterinary and human medicines in the Environment. During this international congress, the following issues will be addressed:
- Methods for exposure assessment
- Modelling approaches
- Effects assessment in the laboratory and field
- Environmental risk assessment
- Strategies for screening and targeting testing
The application of these methodologies will be demonstrated using case studies. The meeting will comprise a number of keynote presentations and poster and paper sessions.
Keynote speakers
- Peter Calow, University of Roskilde, Denmark
- Pharmaceuticals in the environment: a problem invented by rich societies?
- Kornelia Grein, European Medicines Agency, UK
- Regulatory requirements and status of environmental science: do they match?
- Reinhard Länge, Bayer Schering Pharma AG, Germany
- The development process of a human pharmaceutical: Which role plays the environmental risk assessment?
- Chris Metcalfe, Trent University, Canada
- The better analytical methods the bigger environmental problems: a fruitful relationship?
- John Sumpter, Brunel University, UK
- From mammalian to ecotoxicological studies: is the jump too big?